SEC Form 4 research
| Issuer | Theravance Biopharma, Inc. |
|---|---|
| Tickers | TBPH |
| Reporting owners | 43 |
| Officers and directors | 16 |
| Last public filing | 2026-09-17 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-17 | 2026-09-15 | Farnum Rhonda | S | 6,657 | $17.03 | Not reported |
| 2026-09-17 | 2026-09-15 | Farnum Rhonda | S | 3,328 | $17.03 | Not reported |
| 2026-09-17 | 2026-09-15 | Farnum Rhonda | S | 3,329 | $17.03 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.